BMS scores first in class with Zeposia

By Megan Brodie 2 years ago | In Companies, Products
  • 2 years ago
BMS Australia MD Neil MacGregor

21 March 2022 BMS’ sphingosine 1-phosphate (S1P) receptor modulator ZEPOSIA (ozanimod), approved in 2020 for…

This is subscriber-only content. Please login to continue reading.

Recent News

Top Reads